NCT03638167 2025-12-17EGFR806-specific CAR T Cell Locoregional Immunotherapy for EGFR-positive Recurrent or Refractory Pediatric CNS TumorsSeattle Children's HospitalPhase 1 Completed11 enrolled
NCT04185038 2025-12-15Study of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Midline Glioma and Recurrent or Refractory Pediatric Central Nervous System TumorsSeattle Children's HospitalPhase 1 Recruiting90 enrolled